The FDA literally has no authority to set the price of anything. This comes up so often it's actually an FAQ on the FDA website. https://www.fda.gov/about-fda/center-drug-evaluation-and-res....
> We understand that high drug prices have a direct impact on patients—too many American patients are priced out of the medicines they need. However, the FDA has no legal authority to investigate or control the prices set by manufacturers, distributors and retailers.
The funding needs to move on to something that might actually work. Propping up these failed drugs with "what does it hurt" is in the way of getting an Alzheimer's drug that might actually benefit people.
I feel tremendously for patients and their loved ones frustrated with the FDA's sluggishness, but results like these illustrate why it's needed. Especially since many of the drugs have much worse side effects than this one.
Still need some kind of process to weed out the grifts.
And what about their heirs? What if they get conned into wasting away wealth that they could have passed down based on a false idea that it could help them be cured?
Not to mention that it hurts society as a whole to allow money to flow to grifters whether or not the subjects of the con successfully get false hope out of it.
For quickly degenerative diseases maybe we need a different process that takes into account the context of what the drug is used for and what the acceptable risk is by the regulatory bodies. Making the standards and process clear will help provide the framework to reject those with unreasonable demands.
This is the flip side of that.
This was patients lobbying Congress to skip safeguards. The FDA did not want to do this. https://apnews.com/article/science-business-health-lobbying-...
Now it's just getting worse and worse. ALS patient communities used the questionable approval of Aduhelm by desperate Alzheimer’s patients to strongarm the FDA into approving this. Every junk pharma product is now going to come with an advocacy group that says "let's just try it and see".
Grifter pharma corporations will of course take advantage of this. They'll mobilize patient communities to keep skipping the science. And the result will be more wasted lives and more misallocated resources. Instead of working toward drugs that help people, we'll be working toward drugs that sound good to patient communities and Congress. This is a disaster.
The FDA might be slow. But it's slow and deliberate for a reason.